Laboratory Evaluation of a Lateral-Flow Cell for Molecular Detection of First-Line and Second-Line Antituberculosis Drug Resistance.
amikacin
capreomycin
drug susceptibility
extensively drug-resistant tuberculosis
fluoroquinolone
isoniazid
kanamycin
lateral-flow cell
rifampin
tuberculosis
Journal
Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564
Informations de publication
Date de publication:
21 10 2020
21 10 2020
Historique:
received:
05
06
2020
accepted:
12
08
2020
pubmed:
21
8
2020
medline:
24
6
2021
entrez:
21
8
2020
Statut:
epublish
Résumé
Despite the WHO's call for universal drug susceptibility testing for all patients being evaluated for tuberculosis (TB), a lack of rapid diagnostic tests which can fully describe TB resistance patterns is a major challenge in ensuring that all persons diagnosed with drug-resistant TB are started on an appropriate treatment regime. We evaluated the accuracy of the Akonni Biosystems XDR-TB TruArray and lateral-flow cell (XDR-LFC), a novel multiplex assay to simultaneously detect mutations across seven genes that confer resistance to both first- and second-line anti-TB drugs. The XDR-LFC includes 271 discrete three-dimensional gel elements with target-specific probes for identifying mutations in
Identifiants
pubmed: 32817085
pii: JCM.01417-20
doi: 10.1128/JCM.01417-20
pmc: PMC7587100
pii:
doi:
Substances chimiques
Antitubercular Agents
0
Bacterial Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : P30 AI036214
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI111435
Pays : United States
Organisme : NIAID NIH HHS
ID : R44 AI138903
Pays : United States
Informations de copyright
Copyright © 2020 American Society for Microbiology.
Références
J Clin Microbiol. 2014 Feb;52(2):475-82
pubmed: 24478476
J Vis Exp. 2014 Apr 25;(86):
pubmed: 24796567
Emerg Microbes Infect. 2015 Jul;4(7):e42
pubmed: 26251830
PLoS One. 2015 Aug 31;10(8):e0136861
pubmed: 26322781
Int J Tuberc Lung Dis. 2013 Nov;17(11):1479-85
pubmed: 24125454
J Clin Microbiol. 2018 Feb 22;56(3):
pubmed: 29305543
J Clin Microbiol. 2012 Jul;50(7):2404-13
pubmed: 22553245
J Infect Dis. 2015 Apr 1;211 Suppl 2:S21-8
pubmed: 25765103
Biomed Microdevices. 2012 Feb;14(1):45-53
pubmed: 21909803
Eur Respir J. 2017 Dec 28;50(6):
pubmed: 29284687
J Antimicrob Chemother. 2011 Jul;66(7):1417-30
pubmed: 21558086
Indian J Med Res. 2007 Apr;125(4):577-81
pubmed: 17598945
Int J Tuberc Lung Dis. 2008 Dec;12(12):1449-55
pubmed: 19017456
J Clin Microbiol. 2018 Apr 25;56(5):
pubmed: 29540456
Emerg Infect Dis. 2002 Nov;8(11):1310-3
pubmed: 12453362
Sci Rep. 2017 Jun 19;7(1):3790
pubmed: 28630430
PLoS One. 2015 Mar 27;10(3):e0120470
pubmed: 25816236
Lab Chip. 2019 Mar 27;19(7):1217-1225
pubmed: 30801596
J Clin Microbiol. 2014 Mar;52(3):781-9
pubmed: 24353002
J Clin Microbiol. 2014 Jun;52(6):2100-7
pubmed: 24719444